Status:
COMPLETED
Evaluation of Cardiovascular Effects of Smoking Cessation in HIV Patients
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
HIV Infections
Smokers
Eligibility:
All Genders
16+ years
Brief Summary
We will conduct a sub-study of "An Innovative Telephone Intervention for HIV+ Smokers," (NCT00502827) conducted by Drs. Gritz, Vidrine, and others. This is a randomized, prospective trial that will ev...
Detailed Description
HIV/AIDS patients may have an increased risk of myocardial infarction. Traditional risk factors for coronary artery disease, including cigarette smoking, likely play a large role. The prevalence of sm...
Eligibility Criteria
Inclusion
- Patients who meet eligibility criteria for "An innovative telephone intervention for HIV-positive smokers".
- Patients who consent to the sub-study.
- Patients who are able to participate in the study for 3 years.
Exclusion
- Patients with a history of coronary bypass surgery, percutaneous coronary intervention, valve replacement, pacemaker or defibrillator implantation.
Key Trial Info
Start Date :
November 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00918073
Start Date
November 1 2007
End Date
April 1 2013
Last Update
May 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Street Health Center
Houston, Texas, United States, 77009